Literature DB >> 23762660

Purpura Fulminans following Thermal Injury.

Jiongyu Hu1, Xupin Jiang, Ting He, Qizhi Luo.   

Abstract

Purpura fulminans is a rare syndrome of intravascular thrombosis and hemorrhagic infarction of the skin, which is an unusual cutaneous manifestation of disseminated intravascular coagulation. It often occurs in small children and babies due to infection and/or sepsis, rarely in adults in clinic. We report the first case of deadly purpura fulminans following thermal injury in a 64-year-old Chinese woman. The purpura developed sharply and aggravated multiple organ dysfunction. The patient died of purpura fulminans, disseminated intravascular coagulation, and multiple organ dysfunction syndrome.

Entities:  

Year:  2013        PMID: 23762660      PMCID: PMC3665217          DOI: 10.1155/2013/782386

Source DB:  PubMed          Journal:  Case Rep Emerg Med        ISSN: 2090-6498


1. Introduction

Purpura fulminans (PF) is a life-threatening hemorrhagic condition characterized by acute onset hypotension, fever, cutaneous hemorrhage, and necrosis [1]. It is often caused by the infection of Staphylococcus aureus, hemolytic streptococcus and meningococcus [2], and can be classified into three distinct categories: inherited or acquired abnormalities of protein C or other coagulation systems, acute infectious PF, and idiopathic PF [3]. PF often occurs in small children and babies due to infection and/or sepsis, rarely in adults following thermal injury. In this report, we describe a case of PF following alcohol flame thermal injury.

2. Case Presentation

A 64-year-old Chinese woman was admitted to our department with an 18-day history of alcohol flame burn and a 12-hour painful erythema on the right buttocks. Physical examination showed a low-grade fever (37.8°C), burn wounds (2% TBSA) on the left inner thigh covered by traditional Chinese medicine (Figure 1(a)), and petechial rash on the right buttocks (Figure 1(b)). Past medical history and family history were unremarkable. Laboratory findings include haemoglobin anomaly (95 g/L), leukocytosis (15.38 × 109/L), thrombocytopenia (90 × 109/L), and prolonged APTT (69.5 s). Tests of kidney and liver function and abdominal ultrasound showed no abnormality of note.
Figure 1

Photograph of the patient when admitted to the department. (a) Alcohol flame burn covered by traditional Chinese medicine. (b) Painful erythema on the right buttocks.

The purpura developed sharply and occurred on the lower extremities in the next morning. Laboratory tests showed decreased platelet (21 × 109/L), haemoglobin (57 g/L), fibrinogen (0.82 g/L, normal more than 1.8 g/L) and factor VIII activity (29.1%, normal 70%–150%), increased leukocytosis (18.09 × 109/L), D-dimer (30018 ng/mL, normal less than 392 ng/mL), and APTT (67.8 s). Thrombophilia screens displayed low antithrombin III activity (57.1%, normal 75%–125%) but normal protein C and S concentrations. There were no abnormalities in prothrombin time, thrombin time, C3, C4, anticardiolipin, antinuclear, and IgG or IgA antibody levels. The patient was diagnosed with PF and received antibiotics (imipenem, cilastatin sodium, and ticarcillin), fluid resuscitation, and component blood transfusion (fresh frozen plasma and blood platelets) but complicated by new emergence and enlargement of rash, which gradually enlarged into an irregular pattern of full-thickness skin and soft-tissue loss (Figures 2(a)–2(d)). She received bilateral lower extremities escharotomy but developed acute renal failure with anuria 24 h later. Test of kidney and liver function revealed increased creatinine (201 umol/L), glutamic-pyruvic transaminase (391.8 IU/L), and glutamic oxaloacetic transaminase (939.8 IU/L). The blood routine test revealed decreased platelet (11 × 109/L), haemoglobin (40 g/L), and red blood cell (1.34 × 1012/L).
Figure 2

Photograph of the sharply developed purpura. Purpuric rash in the (a) left arm, (b) left lower limbs, (c) buttocks and (d) left ear.

The patient received methylprednisolone treatment, but it did not work. The purpuric rash covered approximately 70% TBSA in the next afternoon, and the platelet count was 9 × 109/L, haemoglobin was 31 g/L, and leukocytosis was 27.28 × 109/L. Test of kidney and liver function revealed increased creatinine (308 umol/L), glutamic-pyruvic transaminase (1354 IU/L), and glutamic-oxalacetic transaminase (4009 IU/L). Myocardial enzyme levels, including creatine kinase and lactic dehydrogenase, were increased notably. The bacterial cultivation indicated Staphylococcus epidermidis and Enterobacter cloacae in burn wound but not in blood, which were sensitive to multiple antibiotics including imipenem, cilastatin sodium, and ticarcillin. Consequently, the patient died on the sixth day after admission of purpura fulminans, disseminated intravascular coagulation, and multiple organ dysfunction syndrome.

3. Discussion

PF is a lethal haemorrhagic condition usually associated with infection and/or sepsis. It occurs mainly in babies and small children, and the mortality rate in the acute phase ranges between 18% and 40% [4]. It is most commonly associated with Neisseria meningitidis sepsis, and proteins C and S and antithrombin III are always involved in the coagulopathy pathogenesis [5, 6]. DIC is believed to be the major pathophysiological mechanism [7]. The abnormal APTT, platelet count, and fibrinogen point towards ongoing coagulopathy as negative prognostic markers. The mainstays of primary management are to remove the underlying cause of clotting abnormalities and with supportive treatment. Protein C supplementation could decrease mortality and morbidity [8], but the safety and efficacy of heparin therapy has not been confirmed [9]. The attention is turned to skin loss management after acute phase, including debridement and grafting, such as escharotomies, fasciotomies, or major amputations. Early escharotomy is recommended in case of amputation [10]. In this case, the PF started by the time that the burn injury approximately healed, and the Staphylococcus epidermidis and Enterobacter cloacae, which were the pathogens of PF, were detected on the wound but not in the blood. Although we used the sensitive antibiotics the first time, the remarkably impressive coagulopathy was ultimately uncontrollable. We suspected that there appears to be a preference for heparin application in cases of ongoing coagulopathy, especially in adults in which the possibility of hereditary proteins S and C deficiency is little.
  10 in total

1.  Photoclinic. Streptococcal purpura fulminans.

Authors:  Naveen Bhardwaj; Sourabh Aggarwal; Alka Sharma; Vishal Sharma
Journal:  Arch Iran Med       Date:  2012-02       Impact factor: 1.354

2.  Purpura fulminans in a child due to Neisseria meningitidis.

Authors:  H Özdemir; T Kendirli; E Çiftçi; E Ince
Journal:  Infection       Date:  2012-06-21       Impact factor: 3.553

3.  [Acute intermediate-risk pulmonary embolism with right-sided free-floating intracardiac thrombus, systemic inflammatory reaction syndrome, multiple organ dysfunction syndrome, disseminated intravascular coagulation and acute ischaemia of a limb].

Authors:  Paweł Grzelakowski; Tomasz Lugowski; Marcin Kurzyna; Maurycy Missima; Michał Maciejewski; Marek Balcerzak; Robert Romanek; Marek Stelak; Andrzej Lugowski; Aleksander Goch
Journal:  Kardiol Pol       Date:  2010-10       Impact factor: 3.108

4.  Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans.

Authors:  O P Smith; B White; D Vaughan; M Rafferty; L Claffey; B Lyons; W Casey
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

5.  [Protein C deficiency in patient with sepsis-associated disseminated intravascular coagulation and deep vein thrombosis].

Authors:  Mauro Tassin; Pablo Llarena; Federico Laffaye; Germán Kaltenbach
Journal:  Arch Argent Pediatr       Date:  2013 Jan-Feb       Impact factor: 0.635

6.  Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients.

Authors:  Alex Veldman; Doris Fischer; Flora Y Wong; Wolfhart Kreuz; Michael Sasse; Bruno Eberspächer; Ulrich Mansmann; Rudolf Schosser
Journal:  Crit Care       Date:  2010-08-19       Impact factor: 9.097

7.  Purpura fulminans in a child: a case report.

Authors:  Shrikiran Aroor; Chaitanya Varma; Suneel C Mundkur
Journal:  J Clin Diagn Res       Date:  2012-12-15

8.  Management of cutaneous manifestations of extensive purpura fulminans in a burn unit.

Authors:  P E Chasan; J F Hansbrough; M L Cooper
Journal:  J Burn Care Rehabil       Date:  1992 Jul-Aug

Review 9.  Purpura fulminans associated with Streptococcus pneumoniae septicemia in an asplenic pediatric patient.

Authors:  S Konda; D Zell; C Milikowski; J Alonso-Llamazares
Journal:  Actas Dermosifiliogr       Date:  2013-09

Review 10.  Modern concepts of the diagnosis and treatment of purpura fulminans.

Authors:  Richard F Edlich; Catherine L Cross; Jill J Dahlstrom; William B Long
Journal:  J Environ Pathol Toxicol Oncol       Date:  2008       Impact factor: 3.567

  10 in total
  1 in total

1.  Identification of differentially expressed serum proteins in infectious purpura fulminans.

Authors:  Ting He; Jiong-yu Hu; Jian Han; Dong-xia Zhang; Xu-pin Jiang; Bing Chen; Yue-sheng Huang
Journal:  Dis Markers       Date:  2014-02-10       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.